APP and Alzheimer disease: According to current knowledge, “A+, T−” −referred to as “Alzheimer’s disease pathologic changes” in the 2018 criteria, reflects underlying brain amyloidopathy [30], which means extracellular deposits of aggregated amyloid beta peptides (amyloid plaques).